comparemela.com

Nasdaq Ocea News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocean Biomedical, Inc Announces Receipt of Notice from

PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a.

United statesRhode islandKevin kertscherOcean biomedical incCommunications directorCompany annual report on formExchange commissionNasdaq stock marketAnnual reportNasdaq listing ruleOcean biomedicalRhode island basedAnnual reportsNasdaq oceaOcean biomedicalNasdaq ocea

Ocean Biomedical, Inc Announces Receipt of Notice from

PROVIDENCE, Rhode Island, Nov. 29, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 22, 2023, it received.

United statesRhode islandKevin kertscherExchange commissionNasdaq stock marketCommunications directorVellar opportunity fundMeteora special opportunity fundStrategy master fundCompany annual report on formOcean biomedical incNasdaq listing ruleOcean biomedicalForward purchase agreementsMeteora select trading opportunities masterPolar multi strategy master

Updated: Ocean Biomedical Announces Non-Dilutive Amendment

Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that the company and Polar Multi-Strategy Master Fund.

United statesKevin kertscherChirinjeev kathuriaOcean biomedical incCommunications directorStrategy master fund polarCompany annual report on formPolar multi strategy master fundSide letterForward purchase agreementReset priceExecutive chairmanRhode island basedOcean biomedicalAnnual reportQuarterly reports

Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now

Ocean Biomedical will host a Research and Development Day, Live Q&A with Scientific Co-founders, Dr. Jack A. Elias, MD and Dr. Jonathan Kurtis, MD, PhD.

United statesKevin kertscherChirinjeev kathuriaJonathan kurtisGurinder kalraJacka eliasResearch corporationWhite lion capitalAlto opportunity master fundOcean biomedical incDevelopment dayCommunications directorCompany annual report on formCompany commentOcean biomedicalScientific co founders

Ocean Biomedical, Inc Enters into a $25 Million

Providence, RI, May 16, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and.

United statesChirinjeev kathuriaWaqas khatriSuren ajjarapuDykema gossettCompany annual report on formKelley drye warrenExchange commissionAlto opportunity master fundMaxim groupOcean biomedical incSenior secured convertible promissory notesOcean biomedicalKelley dryeSecurities purchase agreementCurrent report

vimarsana © 2020. All Rights Reserved.